Commenting on the research published today on BMJ.

Commenting on the research published today on QRisk2 project leader, Professor Julia Hippisley – Cox of the University of Nottingham, said: ‘Based on the study of 15 years of data from more than 2 million British patients QRisk2 is a contemporary and specific risk score that allows CVD risk individually to the individual patient.

Dr David Stables, Clinical Director of EMIS and a Director of Qresearch said: QRisk2 is probably a more efficient tool for treatment decisions have, to support the primary prevention of cardiovascular disease. – We are working on software that enable GPS to QRisk2 easily implemented in clinical practice. .Brigande and colleagues were able hair cells by transferring a gene known Atoh1 spanner Math Math-1) in ‘precursor cells ‘produce mouse develop cells in the inner ear. This type of cell dedicated run different functions during development, according to to the instructions of they genes. This gene is known to cell type. To rotate in Haar cells, but it was not previously known whether the hair cells would normally work when Atoh1 was brought artificially.

We will also continue operate towards ever unwanted unwanted numb into the clinic. ‘John Brigande, Assistant Professor in of Otolaryngology at Oregon Center said Center, said in the OHSU School of Medicine: ‘Our work shows to it possible produce functional auditory hair cells in the cochlea mammalian. ‘.. The most recent research, a team from Oregon Health & Science University found that a key gene as a Atoh1 the art can develop about to cell in hair cells, rather effective operation of those cells how normal hair cells of.